News from the partners – archive
https://amr-accelerator.eu/wp-content/uploads/2024/04/ihi-logo-sqr.jpeg
400
400
Tolga
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Tolga2024-04-26 17:57:552024-04-26 18:04:2922/04/24 – IMI-supported treatment against multidrug-resistant bacteria approved by European Commission
https://amr-accelerator.eu/wp-content/uploads/2024/04/GLG-AMR-logo.jpeg
225
225
Tolga
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Tolga2024-04-26 17:55:072024-04-26 17:36:2203/04/24 – Global Leaders Group on Antimicrobial Resistance calls on UN Member States to take bold and specific action
https://amr-accelerator.eu/wp-content/uploads/2024/04/carbx-logo-col-e1714147248241.png
200
360
Tolga
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Tolga2024-04-26 17:54:592024-04-26 18:00:5605/03/24 – CARB-X FUNDS 100TH PROJECT TARGETING ANTIBIOTIC RESISTANCE
https://amr-accelerator.eu/wp-content/uploads/2024/04/ECDC_Logo-e1714147534878.png
200
225
Tolga
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Tolga2024-04-26 17:34:212024-04-26 18:06:0528/02/24 – Continued efforts needed to fight AMR in humans and animals
https://amr-accelerator.eu/wp-content/uploads/2024/04/AMR-Accelerator_partner_news_2024-3.png
943
943
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2023-07-27 15:52:002024-04-08 15:52:2127/07/23 – EFPIA statement in response to the Commissions Communication on the European Citizen’s initiative on ‘Save Cruelty Free Cosmetics – Commit to a Europe Without Animal Testing
https://amr-accelerator.eu/wp-content/uploads/2023/07/AMR-Accelerator_partner_news_2024-1.png
943
943
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2023-07-25 15:17:372024-04-23 13:59:3225/07/23 – UKHSA launches new strategy to tackle national and global health hazards
https://amr-accelerator.eu/wp-content/uploads/2024/04/AMR-Accelerator_partner_news_2024-2.png
943
943
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2023-06-28 15:47:432024-04-08 15:48:1028/06/23 – Small particles will deliver TB drugs to the lungs in the future
https://amr-accelerator.eu/wp-content/uploads/2023/01/Nosopharm.png
2000
2000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2023-01-25 14:20:042023-07-28 14:50:0625/01/23 – Worm-associated bacteria are an untapped source of antibiotics
https://amr-accelerator.eu/wp-content/uploads/2023/01/HIPS.png
2000
2000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2023-01-23 14:18:192023-07-28 14:50:4623/01/23 – Saarbrücken researchers use bacterial communication as a target for new drugs
https://amr-accelerator.eu/wp-content/uploads/2019/05/Unbenannt18-e1580379932190.png
495
495
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2023-01-18 14:26:332023-07-28 14:37:3918/01/23 – ENABLE-2 Open Call raising international interest
https://amr-accelerator.eu/wp-content/uploads/2022/08/SSI.png
2000
2000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2022-08-30 14:14:062023-07-28 14:51:5230/08/22 – Danish Minister for Health visits the International Vaccine Institute during official visit to Republic of Korea
https://amr-accelerator.eu/wp-content/uploads/2022/01/Partner_PrIMAVeRa_0000_ares.jpg
500
500
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2022-07-26 14:06:272023-07-28 14:06:3726/07/22 – OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven